...
首页> 外文期刊>Ophthalmology >Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS.
【24h】

Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS.

机译:使用导航激光光凝器NAVILAS对糖尿病性黄斑水肿的临床评估和治疗准确性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To evaluate the clinical use and accuracy of a new retinal navigating laser technology that integrates a scanning slit fundus camera system with fluorescein angiography (FA), color, red-free, and infrared imaging capabilities with a computer steerable therapeutic 532-nm laser. DESIGN: Interventional case series. PARTICIPANTS: Eighty-six eyes of 61 patients with diabetic retinopathy and macular edema treated by NAVILAS. METHODS: The imaging included digital color fundus photographs and FA. The planning included graphically marking future treatment sites (microaneurysms for single-spot focal treatment and areas of diffuse leakage for grid pattern photocoagulation) on the acquired images. The preplanned treatment was visible and overlaid on the live fundus image during the actual photocoagulation. The NAVILAS automatically advances the aiming beam location from one planned treatment site to the next after each photocoagulation spot until all sites are treated. Aiming beam stabilization compensated for patient's eye movements. The pretreatment FA with the treatment plan was overlaid on top of the posttreatment color fundus images with the actual laser burns. This allowed treatment accuracy to be calculated. Independent observers evaluated the images to determine if the retinal opacification after treatment overlapped the targeted microaneurysm. MAIN OUTCOME MEASURES: Safety and accuracy of laser photocoagulation. RESULTS: The images were of very good quality compared with standard fundus cameras, allowing careful delineation of target areas on FA. Toggling from infrared, to monochromatic, to color view allowed evaluation and adjustment of burn intensity during treatment. There were no complications during or after photocoagulation treatment. An analysis of accuracy of 400 random focal targeted spots found that the NAVILAS achieved a microaneurysm hit rate of 92% when the placement of the treatment circle was centered by the operating surgeon on the microaneurysm. The accuracy for the control group analyzing 100 focal spots was significantly lower at 72% (P<0.01). CONCLUSIONS: Laser photocoagulation using the NAVILAS system is safe and achieves a higher rate of accuracy in photocoagulation treatments of diabetic retinopathy lesions than standard manual-technique laser treatment. Precise manual preplanning and positioning of the treatment sites by the surgeon is possible, allowing accurate and predictable photocoagulation of these lesions. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
机译:目的:评估一种新型视网膜导航激光技术的临床使用和准确性,该技术将扫描狭缝眼底摄像系统与荧光素血管造影(FA),彩色,无红光和红外成像功能与计算机可控的532 nm激光治疗仪集成在一起。设计:介入案例系列。参与者:NAVILAS治疗的61例糖尿病性视网膜病变和黄斑水肿患者的八十六只眼。方法:成像包括数字彩色眼底照片和FA。计划包括在获取的图像上用图形标记将来的治疗部位(用于单点聚焦治疗的微动脉瘤和用于网格图形光凝的弥散性渗漏区域)。在实际的光凝过程中,可以看到预定的治疗方案并覆盖在实时眼底图像上。 NAVILAS自动将瞄准光束的位置从每个光凝点之后的一个计划的治疗位置推进到下一个治疗位置,直到所有位置都得到治疗。瞄准光束稳定可以补偿患者的眼睛运动。带有治疗计划的预处理FA覆盖在具有实际激光灼伤的治疗后彩色眼底图像之上。这样就可以计算出治疗的准确性。独立的观察者评估了图像,以确定治疗后的视网膜浑浊是否与目标微动脉瘤重叠。主要观察指标:激光光凝的安全性和准确性。结果:与标准眼底照相机相比,图像质量非常好,可以仔细勾画FA上的目标区域。从红外切换到单色,再切换到彩色视图,可以评估和调整治疗过程中的燃烧强度。光凝治疗期间或之后没有并发症。对400个随机聚焦靶点的准确性进行的分析发现,当治疗圆的放置以手术外科医生在微动脉瘤上为中心时,NAVILAS达到了92%的微动脉瘤命中率。对照组分析100个焦点的准确性显着降低,为72%(P <0.01)。结论:使用NAVILAS系统进行激光光凝治疗比标准的手动激光治疗更安全,并且在糖尿病性视网膜病变病变的光凝治疗中具有更高的准确率。外科医生可以对手术部位进行精确的手动预计划和定位,从而可以对这些病变进行准确且可预测的光凝。财务披露:在参考文献之后可以找到专有或商业披露。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号